528 related articles for article (PubMed ID: 33831476)
1. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies.
Liu M; López de Juan Abad B; Cheng K
Adv Drug Deliv Rev; 2021 Jun; 173():504-519. PubMed ID: 33831476
[TBL] [Abstract][Full Text] [Related]
2. Diverse origins and activation of fibroblasts in cardiac fibrosis.
Aujla PK; Kassiri Z
Cell Signal; 2021 Feb; 78():109869. PubMed ID: 33278559
[TBL] [Abstract][Full Text] [Related]
3. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
4. Myocardial fibroblast-matrix interactions and potential therapeutic targets.
Goldsmith EC; Bradshaw AD; Zile MR; Spinale FG
J Mol Cell Cardiol; 2014 May; 70():92-9. PubMed ID: 24472826
[TBL] [Abstract][Full Text] [Related]
5. Activated fibroblasts in cardiac and cancer fibrosis: An overview of analogies and new potential therapeutic options.
Nicolini G; Balzan S; Forini F
Life Sci; 2023 May; 321():121575. PubMed ID: 36933828
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
Svystonyuk DA; Ngu JM; Mewhort HE; Lipon BD; Teng G; Guzzardi DG; Malik G; Belke DD; Fedak PW
J Transl Med; 2015 May; 13():147. PubMed ID: 25948488
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Fibrosis and Fibroblasts.
Kurose H
Cells; 2021 Jul; 10(7):. PubMed ID: 34359886
[TBL] [Abstract][Full Text] [Related]
8. Mechanical stress regulates the mechanotransduction and metabolism of cardiac fibroblasts in fibrotic cardiac diseases.
Tian G; Ren T
Eur J Cell Biol; 2023 Jun; 102(2):151288. PubMed ID: 36696810
[TBL] [Abstract][Full Text] [Related]
9. Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.
Miller CL; Cai Y; Oikawa M; Thomas T; Dostmann WR; Zaccolo M; Fujiwara K; Yan C
Basic Res Cardiol; 2011 Nov; 106(6):1023-39. PubMed ID: 22012077
[TBL] [Abstract][Full Text] [Related]
10. Monocytes increase human cardiac myofibroblast-mediated extracellular matrix remodeling through TGF-β1.
Mewhort HE; Lipon BD; Svystonyuk DA; Teng G; Guzzardi DG; Silva C; Yong VW; Fedak PW
Am J Physiol Heart Circ Physiol; 2016 Mar; 310(6):H716-24. PubMed ID: 26801303
[TBL] [Abstract][Full Text] [Related]
11. Anti-remodeling and anti-fibrotic effects of the neuregulin-1β glial growth factor 2 in a large animal model of heart failure.
Galindo CL; Kasasbeh E; Murphy A; Ryzhov S; Lenihan S; Ahmad FA; Williams P; Nunnally A; Adcock J; Song Y; Harrell FE; Tran TL; Parry TJ; Iaci J; Ganguly A; Feoktistov I; Stephenson MK; Caggiano AO; Sawyer DB; Cleator JH
J Am Heart Assoc; 2014 Oct; 3(5):e000773. PubMed ID: 25341890
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Receptor Nur77 Controls Cardiac Fibrosis through Distinct Actions on Fibroblasts and Cardiomyocytes.
Medzikovic L; Heese H; van Loenen PB; van Roomen CPAA; Hooijkaas IB; Christoffels VM; Creemers EE; de Vries CJM; de Waard V
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562500
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin-6 inhibits cardiac fibroblasts differentiation into myofibroblasts via inactivation of nuclear factor κB signaling.
Tian K; Liu Z; Wang J; Xu S; You T; Liu P
Transl Res; 2015 Mar; 165(3):374-86. PubMed ID: 25475987
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Fibrotic Remodeling on a Chip with Dynamic Mechanical Stimulation.
Kong M; Lee J; Yazdi IK; Miri AK; Lin YD; Seo J; Zhang YS; Khademhosseini A; Shin SR
Adv Healthc Mater; 2019 Feb; 8(3):e1801146. PubMed ID: 30609312
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging of the cardiac extracellular matrix.
de Haas HJ; Arbustini E; Fuster V; Kramer CM; Narula J
Circ Res; 2014 Feb; 114(5):903-15. PubMed ID: 24577969
[TBL] [Abstract][Full Text] [Related]
17. A primer on current progress in cardiac fibrosis.
Al Hattab D; Czubryt MP
Can J Physiol Pharmacol; 2017 Oct; 95(10):1091-1099. PubMed ID: 28273426
[TBL] [Abstract][Full Text] [Related]
18. Novel factors that activate and deactivate cardiac fibroblasts: A new perspective for treatment of cardiac fibrosis.
de Oliveira Camargo R; Abual'anaz B; Rattan SG; Filomeno KL; Dixon IMC
Wound Repair Regen; 2021 Jul; 29(4):667-677. PubMed ID: 34076932
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis.
Molkentin JD; Bugg D; Ghearing N; Dorn LE; Kim P; Sargent MA; Gunaje J; Otsu K; Davis J
Circulation; 2017 Aug; 136(6):549-561. PubMed ID: 28356446
[TBL] [Abstract][Full Text] [Related]
20. Mechanoregulation of cardiac myofibroblast differentiation: implications for cardiac fibrosis and therapy.
Yong KW; Li Y; Huang G; Lu TJ; Safwani WK; Pingguan-Murphy B; Xu F
Am J Physiol Heart Circ Physiol; 2015 Aug; 309(4):H532-42. PubMed ID: 26092987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]